Abstract
Carotid artery stenting (CAS) patients enrolled in the Nanjing Stroke Registry between December 2005 and November 2016. There were 261 patients underwent CAS and digital subtraction angiography, computed tomographic angiography, or duplex ultrasonography 6 months and annually after the procedure. Aspirin and clopidogrel were administered before and after CAS in all patients. Forty-six (17.6%) patients developed recurrent stenosis (> 50% luminal diameter reduction) during a mean follow-up of approximately 1 year. On multivariate analysis, baseline mean platelet volume (MPV) >10.1 fL, lesion length, residual stenosis, and baseline glucose were associated with recurrent stenosis. Patients with MPV >10.1 fL were three times more likely to develop recurrent stenosis after CAS than patients with lower MPVs. Patients with high MPV may benefit from intensified antiplatelet therapy after CAS.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
